Molecular Templates Announces Initiation of Phase II Monotherapy Study of MT-3724 in Relapsed/Refractory Diffuse Large B-Cell Lymphoma Patients by mparnell | Mar 28, 2019 | Portfolio News
European Phase 3 Trial of Aimmune Therapeutics’ AR101 Meets Primary Endpoint by mparnell | Mar 25, 2019 | Portfolio News
Inflazome Receives Funding From the Michael J. Fox Foundation for Parkinson’s Research by mparnell | Mar 24, 2019 | Portfolio News
Aptinyx Reports Fourth Quarter and Full Year 2018 Financial Results and Highlights Pipeline and Business Progress by mparnell | Mar 21, 2019 | Portfolio News
Akebia Therapeutics Announces Preliminary Full-Year 2018 Financial Results and Business Highlights by mparnell | Mar 18, 2019 | Portfolio News